[144] ARTIVION, INC. SEC Filing

Rhea-AI Filing Summary

AORT: A holder filed a Form 144 notice to sell 6,393 shares of common stock through Fidelity Brokerage Services, with an aggregate market value $285,575.31. The filing lists an approximate sale date of 11/14/2025 on the NYSE. Shares outstanding were 47,374,939.

The shares to be sold were acquired on 11/14/2025 via an option originally granted on 03/05/2019, with payment noted as cash. The filing also reports past 3‑month sales by John E. Davis: 3,373 shares on 11/10/2025 for $150,499.55 and 6,563 shares on 11/13/2025 for $300,968.02.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6393	285575.31	47374939	11/14/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/14/2025	Option Granted - 03/05/2019	Issuer			6393	11/14/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John E. Davis 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/10/2025	3373	150499.55
John E. Davis 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/13/2025	6563	300968.02

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AORT’s latest Form 144 filing disclose?

A holder plans to sell 6,393 common shares with an aggregate market value $285,575.31, targeting 11/14/2025 on the NYSE.

How many AORT shares are outstanding as referenced in the filing?

Shares outstanding were 47,374,939.

Who executed recent sales and in what amounts for AORT?

John E. Davis sold 3,373 shares on 11/10/2025 for $150,499.55 and 6,563 shares on 11/13/2025 for $300,968.02.

What is the source of the AORT shares proposed for sale?

They were acquired on 11/14/2025 via an option granted on 03/05/2019, with cash payment.

Which broker is listed for the AORT Form 144 sale?

The broker is Fidelity Brokerage Services LLC.

On which exchange are the AORT shares expected to be sold?

The filing lists the NYSE.